vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and GSI TECHNOLOGY INC (GSIT). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.1M, roughly 1.5× GSI TECHNOLOGY INC). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -234.3%, a 184.6% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 12.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 8.6%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.

FHTX vs GSIT — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.5× larger
FHTX
$9.2M
$6.1M
GSIT
Growing faster (revenue YoY)
FHTX
FHTX
+211.5% gap
FHTX
223.8%
12.2%
GSIT
Higher net margin
GSIT
GSIT
184.6% more per $
GSIT
-49.7%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
8.6%
GSIT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
FHTX
FHTX
GSIT
GSIT
Revenue
$9.2M
$6.1M
Net Profit
$-21.7M
$-3.0M
Gross Margin
52.7%
Operating Margin
-258.2%
-113.7%
Net Margin
-234.3%
-49.7%
Revenue YoY
223.8%
12.2%
Net Profit YoY
-11.1%
25.0%
EPS (diluted)
$-0.35
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
GSIT
GSIT
Q4 25
$9.2M
$6.1M
Q3 25
$8.2M
$6.4M
Q2 25
$7.6M
$6.3M
Q1 25
$6.0M
$5.9M
Q4 24
$2.9M
$5.4M
Q3 24
$7.8M
$4.5M
Q2 24
$6.9M
$4.7M
Q1 24
$5.0M
$5.2M
Net Profit
FHTX
FHTX
GSIT
GSIT
Q4 25
$-21.7M
$-3.0M
Q3 25
$-15.8M
$-3.2M
Q2 25
$-17.9M
$-2.2M
Q1 25
$-18.8M
$-2.2M
Q4 24
$-19.5M
$-4.0M
Q3 24
$-19.1M
$-5.5M
Q2 24
$-23.0M
$1.1M
Q1 24
$-25.0M
$-4.3M
Gross Margin
FHTX
FHTX
GSIT
GSIT
Q4 25
52.7%
Q3 25
54.8%
Q2 25
58.1%
Q1 25
56.1%
Q4 24
54.0%
Q3 24
38.6%
Q2 24
46.3%
Q1 24
51.6%
Operating Margin
FHTX
FHTX
GSIT
GSIT
Q4 25
-258.2%
-113.7%
Q3 25
-226.9%
-49.5%
Q2 25
-279.2%
-34.6%
Q1 25
-385.0%
-38.7%
Q4 24
-840.5%
-74.9%
Q3 24
-305.5%
-122.7%
Q2 24
-386.6%
23.1%
Q1 24
-558.3%
-87.6%
Net Margin
FHTX
FHTX
GSIT
GSIT
Q4 25
-234.3%
-49.7%
Q3 25
-194.4%
-49.4%
Q2 25
-237.3%
-35.3%
Q1 25
-316.4%
-37.9%
Q4 24
-682.9%
-74.4%
Q3 24
-244.9%
-120.0%
Q2 24
-333.6%
23.1%
Q1 24
-495.4%
-83.9%
EPS (diluted)
FHTX
FHTX
GSIT
GSIT
Q4 25
$-0.35
$-0.09
Q3 25
$-0.25
$-0.11
Q2 25
$-0.28
$-0.08
Q1 25
$-0.30
$-0.09
Q4 24
$-0.23
$-0.16
Q3 24
$-0.31
$-0.21
Q2 24
$-0.45
$0.04
Q1 24
$-0.59
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
GSIT
GSIT
Cash + ST InvestmentsLiquidity on hand
$80.9M
$70.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-108.5M
$83.6M
Total Assets
$198.1M
$98.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
GSIT
GSIT
Q4 25
$80.9M
$70.7M
Q3 25
$89.3M
$25.3M
Q2 25
$72.6M
$22.7M
Q1 25
$61.0M
$13.4M
Q4 24
$55.5M
$15.1M
Q3 24
$57.7M
$18.4M
Q2 24
$138.9M
$21.8M
Q1 24
$79.3M
$14.4M
Stockholders' Equity
FHTX
FHTX
GSIT
GSIT
Q4 25
$-108.5M
$83.6M
Q3 25
$-89.7M
$38.6M
Q2 25
$-76.7M
$37.4M
Q1 25
$-61.7M
$28.2M
Q4 24
$-45.5M
$29.9M
Q3 24
$-28.3M
$33.3M
Q2 24
$-14.3M
$38.0M
Q1 24
$-97.5M
$36.0M
Total Assets
FHTX
FHTX
GSIT
GSIT
Q4 25
$198.1M
$98.5M
Q3 25
$205.0M
$52.0M
Q2 25
$226.2M
$50.5M
Q1 25
$258.7M
$43.3M
Q4 24
$284.0M
$44.1M
Q3 24
$308.4M
$47.4M
Q2 24
$328.6M
$52.3M
Q1 24
$255.0M
$42.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
GSIT
GSIT
Operating Cash FlowLast quarter
$-22.3M
$-7.9M
Free Cash FlowOCF − Capex
$-8.2M
FCF MarginFCF / Revenue
-134.4%
Capex IntensityCapex / Revenue
0.0%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
GSIT
GSIT
Q4 25
$-22.3M
$-7.9M
Q3 25
$-18.9M
$-887.0K
Q2 25
$-21.0M
$-1.7M
Q1 25
$-24.0M
$-1.7M
Q4 24
$-24.5M
$-3.6M
Q3 24
$-21.0M
$-3.5M
Q2 24
$-25.5M
$-4.3M
Q1 24
$-29.3M
$-7.1M
Free Cash Flow
FHTX
FHTX
GSIT
GSIT
Q4 25
$-8.2M
Q3 25
$-906.0K
Q2 25
$-21.0M
$-1.7M
Q1 25
$-24.0M
$-1.7M
Q4 24
$-25.0M
$-3.6M
Q3 24
$-21.3M
$-3.5M
Q2 24
$-25.6M
$-4.3M
Q1 24
$-29.4M
$-7.2M
FCF Margin
FHTX
FHTX
GSIT
GSIT
Q4 25
-134.4%
Q3 25
-14.1%
Q2 25
-278.2%
-27.6%
Q1 25
-403.2%
-28.3%
Q4 24
-875.3%
-66.1%
Q3 24
-273.0%
-76.6%
Q2 24
-371.0%
-92.0%
Q1 24
-583.1%
-139.0%
Capex Intensity
FHTX
FHTX
GSIT
GSIT
Q4 25
0.0%
4.9%
Q3 25
0.0%
0.3%
Q2 25
0.3%
0.3%
Q1 25
0.5%
0.1%
Q4 24
16.8%
0.1%
Q3 24
4.0%
0.1%
Q2 24
0.2%
0.7%
Q1 24
2.0%
0.2%
Cash Conversion
FHTX
FHTX
GSIT
GSIT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-3.96×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

GSIT
GSIT

Distribution$5.6M92%
Other$459.0K8%

Related Comparisons